A mission arena that aims to mobilize and align existing and overlapping National (NIS), Sectoral (SIS), Technological (TIS) and Regional (RIS) Innovation System components, struct... nork Joeri Wesseling (16819641)

Gaiak:

General view of weak MIS functions (ovals) and interrelated main MIS barriers (rectangles) in the mission arena (orange) and overall MIS (green). nork Joeri Wesseling (16819641)

Gaiak:

Overview of the different analytical steps. nork Joeri Wesseling (16819641)

Gaiak:

MIS barriers and corresponding mission governance actions to which actors in the mission arena are committed. nork Joeri Wesseling (16819641)

Gaiak:

Overview of strength and weaknesses of the MIS approach. nork Joeri Wesseling (16819641)

Gaiak:

Overview of interviewees. nork Joeri Wesseling (16819641)

Gaiak:

Characteristics of subjects and removed prostheses. nork Janina Golob Deeb (7821854)

Gaiak:

Primers of this study. nork Shuang Li (146392)

Gaiak:

Agarose gel electrophoresis results of PCR products. nork Shuang Li (146392)

Gaiak:

The degradation of PNP by <i>P</i>. <i>putida</i> DLL-E4, DLL-Δ<i>crc</i>, DLL-Δ<i>crc</i>Y, and DLL-Δ<i>crcZ</i>. nork Shuang Li (146392)

Gaiak:

The growth of <i>P</i>. <i>putida</i> DLL-E4, DLL-Δ<i>crc</i>, DLL-Δ<i>crcY</i>, and DLL-Δ<i>crcZ</i> on LB medium. nork Shuang Li (146392)

Gaiak:

Spatial distribution of overall non-carcinogenic risk (HI) for (a) infants, (b) Children, (c) adult females, and (d) adult males posed by potential harmful substances of groundwate... nork Shanhu Xiao (22226759)

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. nork Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. nork Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. nork Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. nork Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. nork Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. nork Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. nork Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. nork Diana M. Hendrickx (1507435)